Volatile Week, but Green? Click to watch the new Podcast.

Calithera Biosciences Stock Forecast

NASDAQ:CALA BUY SELL

$2.42 (-1.63%)

Volume: 39.487k

Closed: Jul 01, 2022

Hollow Logo Score: 1.163

Calithera Biosciences Stock Forecast

BUY SELL NASDAQ:CALA
$2.42 (-1.63%)

Volume: 39.487k

Closed: Jul 01, 2022

Score Hollow Logo 1.163

Calithera Biosciences Stock Price (Quote) NASDAQ:CALA

$2.42 ( -1.63% ) Friday, 1st Jul 2022

Range Low Price High Price Comment
30 days $0.14 $2.99 Friday, 1st Jul 2022 CALA stock ended at $2.42. This is 1.63% less than the trading day before Thursday, 30th Jun 2022. During the day the stock fluctuated 4.56% from a day low at $2.41 to a day high of $2.52.
90 days $0.14 $2.99
52 weeks $0.14 $2.99

Historical Calithera Biosciences prices

Date Open High Low Close Volume
2022-07-01 $2.46 $2.52 $2.41 $2.42 39 487
2022-06-30 $2.50 $2.59 $2.39 $2.46 47 500
2022-06-29 $2.85 $2.89 $2.52 $2.55 107 199
2022-06-28 $2.85 $2.99 $2.76 $2.86 51 831
2022-06-27 $2.66 $2.90 $2.64 $2.87 66 492
2022-06-24 $2.64 $2.74 $2.54 $2.60 96 856
2022-06-23 $2.37 $2.61 $2.37 $2.59 108 305
2022-06-22 $2.41 $2.50 $2.37 $2.41 94 366
2022-06-21 $2.73 $2.83 $2.41 $2.42 264 811
2022-06-17 $2.57 $2.85 $2.57 $2.70 184 969
2022-06-16 $2.55 $2.72 $2.31 $2.58 404 383
2022-06-15 $2.46 $2.81 $2.34 $2.75 346 262
2022-06-14 $0.20 $0.21 $0.14 $0.14 6 146 268
2022-06-13 $0.22 $0.23 $0.20 $0.20 1 656 374
2022-06-10 $0.24 $0.25 $0.22 $0.24 3 186 333
2022-06-09 $0.23 $0.25 $0.22 $0.24 3 614 397
2022-06-08 $0.20 $0.24 $0.20 $0.23 4 675 785
2022-06-07 $0.21 $0.22 $0.19 $0.20 6 938 008
2022-06-06 $0.20 $0.20 $0.18 $0.19 1 615 704
2022-06-03 $0.20 $0.21 $0.19 $0.20 1 486 045
2022-06-02 $0.20 $0.20 $0.19 $0.20 846 275
2022-06-01 $0.20 $0.21 $0.20 $0.20 1 041 393
2022-05-31 $0.21 $0.22 $0.20 $0.21 1 563 735
2022-05-27 $0.20 $0.21 $0.19 $0.21 2 731 463
2022-05-26 $0.20 $0.21 $0.19 $0.20 4 688 514
2022-05-25 $0.20 $0.22 $0.18 $0.20 4 628 790
2022-05-24 $0.23 $0.23 $0.20 $0.21 2 346 996
2022-05-23 $0.22 $0.24 $0.22 $0.22 1 600 493
2022-05-20 $0.21 $0.23 $0.21 $0.23 2 117 945
2022-05-19 $0.18 $0.22 $0.18 $0.21 3 348 144
2022-05-18 $0.22 $0.22 $0.19 $0.19 1 539 084
2022-05-17 $0.23 $0.23 $0.20 $0.22 3 773 621
2022-05-16 $0.19 $0.23 $0.19 $0.22 3 200 374
2022-05-13 $0.20 $0.23 $0.18 $0.23 20 435 398
2022-05-12 $0.16 $0.18 $0.15 $0.16 4 653 125
2022-05-11 $0.21 $0.21 $0.16 $0.16 7 847 922
2022-05-10 $0.22 $0.22 $0.20 $0.20 2 027 133
2022-05-09 $0.23 $0.24 $0.20 $0.20 3 192 274
2022-05-06 $0.23 $0.24 $0.23 $0.24 1 381 375
2022-05-05 $0.26 $0.26 $0.23 $0.24 3 240 576
2022-05-04 $0.25 $0.26 $0.24 $0.26 2 119 760
2022-05-03 $0.25 $0.26 $0.24 $0.25 1 770 727
2022-05-02 $0.25 $0.26 $0.24 $0.25 1 499 057
2022-04-29 $0.26 $0.27 $0.23 $0.25 2 782 048
2022-04-28 $0.25 $0.27 $0.25 $0.27 2 362 378
2022-04-27 $0.25 $0.26 $0.25 $0.25 1 278 556
2022-04-26 $0.28 $0.28 $0.25 $0.25 2 139 060
2022-04-25 $0.32 $0.32 $0.26 $0.28 5 495 428
2022-04-22 $0.34 $0.35 $0.31 $0.32 1 543 206
2022-04-21 $0.37 $0.40 $0.34 $0.36 23 671 000

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 722 stocks, only a few dozen will trigger such a signal!

About Calithera Biosciences

Calithera Biosciences Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myelom... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT